Overview
Also known as:
FDA & Trial Timeline
5 eventsQilu Pharmaceutical Co., Ltd. — PHASE1
Luye Pharma Group Ltd. — PHASE1
Hoffmann-La Roche — PHASE1
Shanghai Xitaili Biomedicine Technology co., Ltd. — PHASE1
Zhejiang Hanmai Pharmaceutical Technology Co., Ltd. — PHASE1
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Isolated micronodular adrenocortical disease.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Isolated micronodular adrenocortical disease at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Isolated micronodular adrenocortical disease.
Community
No community posts yet. Be the first to share your experience with Isolated micronodular adrenocortical disease.
Start the conversation →Latest news about Isolated micronodular adrenocortical disease
Disease timeline:
New recruiting trial: A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO7669330 in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
A new clinical trial is recruiting patients for Isolated micronodular adrenocortical disease
New recruiting trial: A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020
A new clinical trial is recruiting patients for Isolated micronodular adrenocortical disease
New recruiting trial: MAD Study to Assess the Safety, Tolerability, PKs and Efficacy of YJ001 for Spray Use in Patients With DPNP
A new clinical trial is recruiting patients for Isolated micronodular adrenocortical disease
New recruiting trial: Phase I Study of XTL6001 Injection in Healthy and Obese Subjects
A new clinical trial is recruiting patients for Isolated micronodular adrenocortical disease
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Isolated micronodular adrenocortical disease
Which specialists treat Isolated micronodular adrenocortical disease?
1 specialists and care centers treating Isolated micronodular adrenocortical disease are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.